Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Anagrelide/hydroxycarbamide

Essential thrombocythaemia transformation to AML or MDS: 17 case reports

    • 17 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Bowers JW, Liu J, Zuckerman KS, Naghashpour M, Lancet J, Komrokji RS, Moscinski LC, Zhang L.Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Transformation From Essential Thrombocythemia (ET) In Patients Treated with Hydroxyurea or Anagrelide: A Single Center Series of 17 Cases. 52nd Annual Meeting and Exposition of the American Society of Hematology: abstr. 4102, 4 Dec 2010. Available from: URL: http://www.hematology.org - USA

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Anagrelide/hydroxycarbamide. React. Wkly. 1334, 8 (2011). https://doi.org/10.2165/00128415-201113340-00028

    Download citation

    Keywords

    • Public Health
    • Stem Cell
    • Patient Outcome
    • Combine Effect
    • Congenital Anomaly